NCT02557126View on ClinicalTrials.gov

Study of URC102 to Assess the Safety and Efficacy in Gout Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

76

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions

GoutHyperuricemia

Interventions

DRUG

URC102

DRUG

Placebo

Trial Locations (1)

137-864

JW Pharmaceutical, Seoul

Sponsors

Lead Sponsor

JW Pharmaceutical

All Listed Sponsors

lead

JW Pharmaceutical

INDUSTRY